Compare Stocks → why 99.94% won’t make you money (From Prosper Trading Academy) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDigital Media StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare ShareLink copied to clipboard. NASDAQ:FTSV Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFTSVForty Seven$95.51$95.51$5.53▼$95.51$4.60B0.41.61 million shsN/A12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFTSVForty Seven0.00%0.00%0.00%0.00%0.00%The Military's $700M "AI Software Bullet" (Ad)The Pentagon is spending over $700 MILLION on a top-secret project called "Overmatch." It's a software-defined networking solution that will connect all sensors, weapons, platforms, and personnel across our military branches.Get the name and stock ticker of this critical military tech firm HERE>>>MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFTSVForty SevenN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFTSVForty SevenN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFTSVForty Seven$15.68M293.33N/AN/A$7.52 per share12.70Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFTSVForty Seven-$87.62M-$2.34N/AN/AN/AN/A-50.38%-44.35%N/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFTSVForty SevenN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFTSVForty SevenN/A14.8114.81OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFTSVForty Seven71.77%Insider OwnershipCompanyInsider OwnershipFTSVForty Seven37.40%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableFTSVForty Seven5748.16 millionN/ANot OptionableENGI, FTSV, BERM, and SPPC HeadlinesRecent News About These CompaniesMay 28, 2024 | msn.com49ers happy to see Nick Bosa at voluntary OTAsMay 2, 2024 | msn.com95.7 The Game hosts warn 49ers' first-round pick not to say 'San Fran'April 28, 2024 | msn.comUSS Forrestal: Triumph and Tragedy of America's First 'Super' Aircraft CarrierApril 27, 2024 | ninerswire.usatoday.comNFL Twitter reacts to 49ers drafting Florida State CB Renardo Green in second roundApril 11, 2024 | fftimes.comStudy Finds DULF Reduced Overdoses by Distributing Tested DrugsApril 9, 2024 | msn.com49ers sign veteran tight endMarch 28, 2024 | msn.comParent Of FTX Victim Who Lost $130K Recommends Six-Year Sentence For Sam Bankman-Fried, Countering DOJ's 40-50 YearsJanuary 30, 2024 | deadline.comFathom Events Sets March Release For ‘Forty-Seven Days With Jesus’December 23, 2023 | en.mercopress.comForty US states filed a lawsuit against pharmaceutical firms colluding oligopolyNovember 16, 2023 | morningstar.comFormula Systems (1985) Ltd ADR FORTYOctober 27, 2023 | nypost.comSix young men found dead, one injured in search for seven abducted Mexican teenagersOctober 10, 2023 | bizjournals.com$18M upgrade makes historic downtown Milwaukee high-rise a modern data centerSeptember 15, 2023 | buffalorising.comForty Thieves Kitchen & BarSeptember 11, 2023 | msn.comTampa radio station 101.5 has changed from Top 40 to R&B formatAugust 28, 2023 | education.comSeven Times Tables PracticeAugust 26, 2023 | zigwheels.comJawa Forty Two SpecificationsAugust 18, 2023 | msn.comJRA Chair: Seven businesses coming to Farish StreetJuly 21, 2023 | ign.comThe Seven HarrysJuly 10, 2023 | en.mercopress.comForty years ago Watergate forced Nixon to became the only US president to resignJuly 9, 2023 | hackaday.comseven segment displayTop HeadlinesView All HeadlinesIntel's Secret Plan for a Double-Digit Stock Rally RevealedBy Gabriel Osorio-Mazilli | June 7, 2024View Intel's Secret Plan for a Double-Digit Stock Rally RevealedTop 3 Stocks Set to Soar with the AI-Driven Metaverse RevolutionBy Thomas Hughes | June 10, 2024View Top 3 Stocks Set to Soar with the AI-Driven Metaverse RevolutionTop 4 Fastest Growing S&P 500 Dividends: Buy, Sell, or Hold?By Thomas Hughes | June 12, 2024View Top 4 Fastest Growing S&P 500 Dividends: Buy, Sell, or Hold?Autodesk Raises Guidance After Clearing Audit Investigation By Jea Yu | June 10, 2024View Autodesk Raises Guidance After Clearing Audit Investigation Sportradar Rides the Sports Betting Trend From Behind the CurtainBy Jea Yu | May 22, 2024View Sportradar Rides the Sports Betting Trend From Behind the CurtainCompany DescriptionsForty SevenNASDAQ:FTSVForty Seven Inc., a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibody against CD47 that is in Phase 1b/2 clinical trials used for the treatment of cancer; FSI-189, an antibody that binds to SIRPa; and FSI-174, an anti-cKIT antibody. Forty Seven Inc. has a collaboration agreement with Genentech to include third clinical trial in non-Hodgkin's lymphoma. The company was formerly known as CD47 Sciences, Inc. Forty Seven Inc. was incorporated in 2014 and is headquartered in Menlo Park, California. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
